M&A Deal Summary

KBI Biopharma Acquires Elion

On January 22, 2018, KBI Biopharma acquired life science company Elion

Acquisition Highlights
  • This is KBI Biopharma’s 2nd transaction in the Life Science sector.
  • This is KBI Biopharma’s 2nd transaction in the United States.
  • This is KBI Biopharma’s 1st transaction in Colorado.

M&A Deal Summary

Date 2018-01-22
Target Elion
Sector Life Science
Buyer(s) KBI Biopharma
Deal Type Add-on Acquisition

Target

Elion

Louisville, Colorado, United States
Elion LLC is a provider of an analytical method development, qualification and validation; analytical characterization testing of biologics; formulation development; training in highly specialized analytical techniques; comprehensive data analysis including visualization and interpretation of complex data sets; technical and regulatory writing; and technical consulting. Elion is based is Louisville, Colorado.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

KBI Biopharma

Durham, North Carolina, United States

Category Company
Founded 1996
Sector Life Science
DESCRIPTION

KBI Biopharma, Inc. is a contract biopharmaceutical development, enhancing drug value by bringing products to market more rapidly and efficiently.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: Colorado M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-15 Alliance Protein Laboratories

San Diego, California, United States

Alliance Protein Laboratories, Inc. is a contract research and consulting firm specializing in biophysical analysis. It offers a broad range of biophysical characterization services, contract purification services (research scale), and consulting services.

Buy -